Allogeneic Stem Cell Transplantation: Clinical Trials

1 trial for Allogeneic Stem Cell Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Valganciclovir, Ganciclovir - Allogeneic Stem Cell Transplantation
Phase 3TerminatedPierrel Research Europe GmbH2122010-09-012012-12-10

Narrower conditions

Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)

Broader conditions

Amino Acid Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mitochondrial Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Ganciclovir (1)  ·  Valganciclovir (1)

Sponsors

Pierrel Research Europe GmbH (1)

Countries

Austria (1)  ·  Germany (1)  ·  Spain (1)

Top investigators

Hermann Einsele, Prof. Dr. (1)